ConductScience.org, home

Comparison · NCT01497067-sae

CACHET - Ocular vs CACHET - Systemic: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. CACHET - Ocular vs CACHET - Systemic: serious adverse events. Trial comparisons, record NCT01497067-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01497067-sae

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.2460.2210.272wilson
Risk in group 20.03650.02470.0538wilson
Risk difference, group 1 minus group 20.2090.1790.238newcombe hybrid score
Risk ratio, group 1 over group 26.734.4810.1log
Odds ratio, group 1 over group 28.595.5913.2log
Number needed to harm, for one more participant with a serious adverse event on CACHET - Ocular than on CACHET - Systemic4.784.25.57from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1CACHET - OcularAll eyes previously implanted with ACRYSOF CACHET Phakic Lens (L-series)2761,123EG000
Group 2CACHET - SystemicAll subjects previously implanted with ACRYSOF CACHET Phakic Lens (L-series)24657EG001

Harm

What it counts
Total, serious adverse events
Time frame
Adverse events were collected from time of enrollment until study exit for an individual duration up to 6 years based on time of enrollment.

Source ClinicalTrials.gov

Trial

Title
Long Term Safety Protocol for the AcrySof CACHET Phakic Lens
NCT number
NCT01497067
Phases
NA
Conditions
Myopia
Interventions
ACRYSOF CACHET Phakic Lens (L-series)
Lead sponsor
Alcon Research
Results first posted
2019-06-26

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01497067-sae